Exploring the Role of the Gut Microbiome in HIV Reservoir Behavior
-
By
-
Christopher M Basting
-
Nichole R Klatt
-
December 9, 2025
Clinical Scorecard: Exploring the Role of the Gut Microbiome in HIV Reservoir Behavior
At a Glance
| Category | Detail |
|---|---|
| Condition | HIV infection with persistent viral reservoirs despite ART |
| Key Mechanisms | Gut microbiome dysbiosis alters immune activation and gut barrier integrity, influencing HIV reservoir dynamics |
| Target Population | People with HIV (PWH) on antiretroviral therapy |
| Care Setting | HIV clinical management and research settings focusing on reservoir and microbiome interactions |
Key Highlights
- HIV reservoirs persist in the gastrointestinal tract despite ART, contributing to chronic immune activation and comorbidities.
- Gut microbiome dysbiosis in HIV leads to impaired gut barrier, microbial translocation, and systemic inflammation.
- Microbial composition and HIV reservoir size vary along the gastrointestinal tract with complex, segment-specific associations.
Guideline-Based Recommendations
Diagnosis
- Consider gastrointestinal tract sampling beyond stool and rectal swabs for accurate microbiome and HIV reservoir assessment.
Management
- Maintain ART to control HIV replication but recognize persistent reservoirs and immune activation.
- Investigate microbiome-targeted interventions to modulate immune activation and reservoir dynamics.
Monitoring & Follow-up
- Monitor immune activation markers and gut microbiome composition as potential indicators of reservoir behavior and treatment response.
Risks
- Persistent microbial translocation and dysbiosis contribute to chronic inflammation, T-cell exhaustion, and increased morbidity.
- Proinflammatory microbiome profiles may both facilitate viral control and impair immunotherapy efficacy.
Patient & Prescribing Data
People with HIV on ART with persistent viral reservoirs
Baseline gut microbiome composition may influence viral rebound timing and response to immunotherapies such as latency-reversing agents and cytokine therapies.
Clinical Best Practices
- Recognize the gastrointestinal tract as a critical site for HIV reservoir persistence and immune activation.
- Account for confounding factors affecting the gut microbiome including diet, sexual behavior, and ART regimen.
- Use comprehensive sampling approaches for microbiome and reservoir studies to capture segment-specific dynamics.
- Consider the dual role of proinflammatory microbiomes in both viral control and potential immunotherapy resistance.
References
- Trunfio et al study on gut microbiome and HIV reservoir
- HIV reservoir persistence and immune activation mechanisms
- Microbial translocation and chronic inflammation in HIV
Based on findings from:
Dissecting the Impact of the Gut Microbiome on HIV Reservoir Dynamics
Christopher M Basting, Nichole R Klatt. The Journal Of Infectious Diseases, 2025.
https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaf560/8374741
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
